Global Artificial Pancreas Devices System Market Insights, Forecast to 2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Artificial Pancreas Devices System Revenue
• 1.4 Market by Type
  • 1.4.1 Global Artificial Pancreas Devices System Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Threshold Suspend Device System
  • 1.4.3 Non-Threshold Suspend Device System (NTSDS)
  • 1.4.4 Control to Range System (CTRS)
  • 1.4.5 Control to Target System (CTTS)
• 1.5 Market by Application
  • 1.5.1 Global Artificial Pancreas Devices System Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Artificial Pancreas Devices System Market Perspective (2015-2026)
• 2.2 Global Artificial Pancreas Devices System Growth Trends by Regions
  • 2.2.1 Artificial Pancreas Devices System Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Artificial Pancreas Devices System Historic Market Share by Regions (2015-2020)
  • 2.2.3 Artificial Pancreas Devices System Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Artificial Pancreas Devices System Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Artificial Pancreas Devices System Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Artificial Pancreas Devices System Players by Market Size
  • 3.1.1 Global Top Artificial Pancreas Devices System Players by Revenue (2015-2020)
  • 3.1.2 Global Artificial Pancreas Devices System Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Artificial Pancreas Devices System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Artificial Pancreas Devices System Market Concentration Ratio
  • 3.2.1 Global Artificial Pancreas Devices System Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Artificial Pancreas Devices System Revenue in 2019
• 3.3 Artificial Pancreas Devices System Key Players Head office and Area Served
• 3.4 Key Players Artificial Pancreas Devices System Product Solution and Service
• 3.5 Date of Enter into Artificial Pancreas Devices System Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Artificial Pancreas Devices System Historic Market Size by Type (2015-2020)
• 4.2 Global Artificial Pancreas Devices System Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Artificial Pancreas Devices System Market Size by Application (2015-2020)
• 5.2 Global Artificial Pancreas Devices System Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Artificial Pancreas Devices System Market Size (2015-2020)
• 6.2 Artificial Pancreas Devices System Key Players in North America (2019-2020)
• 6.3 North America Artificial Pancreas Devices System Market Size by Type (2015-2020)
• 6.4 North America Artificial Pancreas Devices System Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Artificial Pancreas Devices System Market Size (2015-2020)
• 7.2 Artificial Pancreas Devices System Key Players in Europe (2019-2020)
• 7.3 Europe Artificial Pancreas Devices System Market Size by Type (2015-2020)
• 7.4 Europe Artificial Pancreas Devices System Market Size by Application (2015-2020)

8 China

• 8.1 China Artificial Pancreas Devices System Market Size (2015-2020)
• 8.2 Artificial Pancreas Devices System Key Players in China (2019-2020)
• 8.3 China Artificial Pancreas Devices System Market Size by Type (2015-2020)
• 8.4 China Artificial Pancreas Devices System Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Artificial Pancreas Devices System Market Size (2015-2020)
• 9.2 Artificial Pancreas Devices System Key Players in Japan (2019-2020)
• 9.3 Japan Artificial Pancreas Devices System Market Size by Type (2015-2020)
• 9.4 Japan Artificial Pancreas Devices System Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Artificial Pancreas Devices System Market Size (2015-2020)
• 10.2 Artificial Pancreas Devices System Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Artificial Pancreas Devices System Market Size by Type (2015-2020)
• 10.4 Southeast Asia Artificial Pancreas Devices System Market Size by Application (2015-2020)

11 India

• 11.1 India Artificial Pancreas Devices System Market Size (2015-2020)
• 11.2 Artificial Pancreas Devices System Key Players in India (2019-2020)
• 11.3 India Artificial Pancreas Devices System Market Size by Type (2015-2020)
• 11.4 India Artificial Pancreas Devices System Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Artificial Pancreas Devices System Market Size (2015-2020)
• 12.2 Artificial Pancreas Devices System Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Artificial Pancreas Devices System Market Size by Type (2015-2020)
• 12.4 Central & South America Artificial Pancreas Devices System Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Medtronic
  • 13.1.1 Medtronic Company Details
  • 13.1.2 Medtronic Business Overview
  • 13.1.3 Medtronic Artificial Pancreas Devices System Introduction
  • 13.1.4 Medtronic Revenue in Artificial Pancreas Devices System Business (2015-2020))
  • 13.1.5 Medtronic Recent Development
• 13.2 Johnson & Johnson
  • 13.2.1 Johnson & Johnson Company Details
  • 13.2.2 Johnson & Johnson Business Overview
  • 13.2.3 Johnson & Johnson Artificial Pancreas Devices System Introduction
  • 13.2.4 Johnson & Johnson Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.2.5 Johnson & Johnson Recent Development
• 13.3 Insulet
  • 13.3.1 Insulet Company Details
  • 13.3.2 Insulet Business Overview
  • 13.3.3 Insulet Artificial Pancreas Devices System Introduction
  • 13.3.4 Insulet Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.3.5 Insulet Recent Development
• 13.4 Tandem Diabetes Care
  • 13.4.1 Tandem Diabetes Care Company Details
  • 13.4.2 Tandem Diabetes Care Business Overview
  • 13.4.3 Tandem Diabetes Care Artificial Pancreas Devices System Introduction
  • 13.4.4 Tandem Diabetes Care Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.4.5 Tandem Diabetes Care Recent Development
• 13.5 Roche
  • 13.5.1 Roche Company Details
  • 13.5.2 Roche Business Overview
  • 13.5.3 Roche Artificial Pancreas Devices System Introduction
  • 13.5.4 Roche Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.5.5 Roche Recent Development
• 13.6 Beta Bionics
  • 13.6.1 Beta Bionics Company Details
  • 13.6.2 Beta Bionics Business Overview
  • 13.6.3 Beta Bionics Artificial Pancreas Devices System Introduction
  • 13.6.4 Beta Bionics Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.6.5 Beta Bionics Recent Development
• 13.7 Bigfoot Biomedical
  • 13.7.1 Bigfoot Biomedical Company Details
  • 13.7.2 Bigfoot Biomedical Business Overview
  • 13.7.3 Bigfoot Biomedical Artificial Pancreas Devices System Introduction
  • 13.7.4 Bigfoot Biomedical Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.7.5 Bigfoot Biomedical Recent Development
• 13.8 Cellnovo
  • 13.8.1 Cellnovo Company Details
  • 13.8.2 Cellnovo Business Overview
  • 13.8.3 Cellnovo Artificial Pancreas Devices System Introduction
  • 13.8.4 Cellnovo Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.8.5 Cellnovo Recent Development
• 13.9 Dexcom
  • 13.9.1 Dexcom Company Details
  • 13.9.2 Dexcom Business Overview
  • 13.9.3 Dexcom Artificial Pancreas Devices System Introduction
  • 13.9.4 Dexcom Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.9.5 Dexcom Recent Development
• 13.10 Dose Safety
  • 13.10.1 Dose Safety Company Details
  • 13.10.2 Dose Safety Business Overview
  • 13.10.3 Dose Safety Artificial Pancreas Devices System Introduction
  • 13.10.4 Dose Safety Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 13.10.5 Dose Safety Recent Development
• 13.11 DreaMed Diabetes
  • 10.11.1 DreaMed Diabetes Company Details
  • 10.11.2 DreaMed Diabetes Business Overview
  • 10.11.3 DreaMed Diabetes Artificial Pancreas Devices System Introduction
  • 10.11.4 DreaMed Diabetes Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 10.11.5 DreaMed Diabetes Recent Development
• 13.12 Inreda Diabetic
  • 10.12.1 Inreda Diabetic Company Details
  • 10.12.2 Inreda Diabetic Business Overview
  • 10.12.3 Inreda Diabetic Artificial Pancreas Devices System Introduction
  • 10.12.4 Inreda Diabetic Revenue in Artificial Pancreas Devices System Business (2015-2020)
  • 10.12.5 Inreda Diabetic Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer